TrialCirculation research2014

Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes.

Christopher R Cogle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.